Clermont-Ferrand, France

Henri Pourrat


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Henri Pourrat in Pharmaceutical Preparations

Introduction

Henri Pourrat is a notable inventor based in Clermont-Ferrand, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable oxaliplatinum preparations for parenteral administration. With a total of two patents to his name, Pourrat's work is recognized for its innovative approach to drug formulation.

Latest Patents

Pourrat's latest patents include a pharmaceutically stable oxaliplatinum preparation for parenteral administration. This invention focuses on creating a clear and colorless solution of oxaliplatinum that remains stable over time. The preparation involves a solvent containing at least 7 mg/ml of oxaliplatinum and includes hydroxylated derivatives such as 1,2-propanediol, glycerol, maltitol, saccharose, and inositol. Another significant patent is for a pharmaceutical oxaliplatinum preparation that has undergone wet heat treatment with steam under pressure, ensuring stability and efficacy for parenteral use.

Career Highlights

Pourrat is currently associated with Debiopharm S.A., a company known for its commitment to advancing pharmaceutical innovations. His work at Debiopharm has allowed him to focus on developing cutting-edge solutions that enhance patient care and treatment outcomes.

Collaborations

Throughout his career, Pourrat has collaborated with talented professionals such as Houssam Ibrahim and Christine Deuschel. These collaborations have contributed to the successful development of his patented inventions and have fostered a collaborative environment for innovation.

Conclusion

Henri Pourrat's contributions to pharmaceutical preparations exemplify the importance of innovation in medicine. His patents reflect a commitment to improving drug stability and efficacy, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…